APS Pharmacy recalls testosterone cypionate/dhea injectable vials (lot numbers 746000 and 751472) due to lack of sterility assurance. Consumers should contact APS Pharmacy for details.
Lack of sterility assurance.
APS Pharmacy is recalling testosterone cypionate/dhea injectable vials that may not be sterile. This could lead to infections if used.
The vials lack sterility assurance, meaning they could be contaminated with bacteria. If injected, this could cause infections or other health issues.
People who have received the recalled testosterone cypionate/dhea injectable vials (lot numbers 746000 or 751472) are affected. Those using the product for medical purposes are at risk.
Check the vial label for lot numbers 746000 (BUD: 6/26/2022) or 751472 (BUD: 7/20/2022). The product is sold by APS Pharmacy.
Look for lot numbers 746000 or 751472 on the vial label.
The recall states there is a lack of sterility assurance, so it may not be safe to use.
Check the vial label for lot numbers 746000 (BUD: 6/26/2022) or 751472 (BUD: 7/20/2022).
The recall does not specify a remedy, so contact APS Pharmacy for further instructions.
We’ve drafted a message you can send APS Pharmacy to request your refund or repair — edit it as you like.
Subject: Recall D-0732-2022 — APS Pharmacy APS Pharmacy Hello, I own a APS Pharmacy that is covered by recall D-0732-2022 from APS Pharmacy. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
